COVID-19 and Pregnancy: Vertical Transmission and Inflammation Impact on Newborns
- PMID: 33921113
- PMCID: PMC8071483
- DOI: 10.3390/vaccines9040391
COVID-19 and Pregnancy: Vertical Transmission and Inflammation Impact on Newborns
Abstract
The COVID-19 pandemic is ongoing and we are still compiling new findings to decipher and understand SARS-CoV-2 infection during pregnancy. No reports encompass any conclusive confirmation of vertical transmission. Nevertheless, cases of fetal distress and multiple organ failure have been reported, as well as rare cases of fetal demise. While clinicians and scientists continue to seek proof of vertical transmission, they miss the greater point, namely the cause of preterm delivery. In this review, we suggest that the cause might not be due to the viral infection but the fetal exposure to maternal inflammation or cytokine storm that translates into a complication of COVID-19. This statement is extrapolated from previous experience with infections and inflammation which were reported to be fatal by increasing the risk of preterm delivery and causing abnormal neonatal brain development and resulting in neurological disorders like atypical behavioral phenotype or autistic syndrome. Given the potentially fatal consequences on neonate health, we highlight the urgent need for an animal model to study vertical transmission. The preclinical model will allow us to make the link between SARS-COV-2 infection, inflammation and long-term follow-up of child brain development.
Keywords: COVID-19; central nervous system; fetus; immunity; inflammation; neurodevelopmental disorders; newborn; preterm delivery; transmission.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- WHO. [(accessed on 31 July 2020)]; Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-a....
-
- Johns Hopkins University Medicine. [(accessed on 30 March 2021)];2020 Available online: https://coronavirus.jhu.edu/map.html.
-
- Richardson S., Hirsch J.S., Narasimhan M., Crawford J.M., McGinn T., Davidson K.W., Barnaby D.P., Becker L.B., Chelico J.D., Cohen S.L. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323:2052–2059. doi: 10.1001/jama.2020.6775. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
